Biotech

All Articles

Basilea ratings $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job cultivating brand new antifungals has gotten a substantial improvement ...

Capricor markets Europe legal rights to late-stage DMD treatment for $35M

.Possessing actually scooped up the USA rights to Capricor Therapeutics' late-stage Duchenne muscula...

FDA fragments adcomm for Applied's unusual disease medication

.After pushing the choice meeting for Applied Therapeutics' metabolic ailment medicine govorestat, t...

Novo inks $600M NanoVation package to study hereditary medications ex-liver

.Novo Nordisk is actually continuing its own push into genetic medicines, accepting to compensate Na...

Innovent web links cytokine to intestines cancer cells feedbacks

.Innovent Biologics has made the situation that its gate inhibitor-cytokine blend healthy protein po...

Merck, Daiichi ADC attacks goal in stage 3 bronchi cancer research

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina grows AI focus with collab to select cancer cells targets

.5 months after Rakovina Rehabs turned toward expert system, the cancer-focused biotech has joined f...

Ascendis' dwarfism medicine favorites in phase 3, threatens BioMarin

.Ascendis Pharma has actually emerged as a potential danger to BioMarin's Voxzogo, stating period 3 ...

Despite ph. 3 miss out on, Alkeus finds path ahead of time for eye health condition resource

.Though Alkeus Pharmaceuticals' dental eye disease possession fell short to substantially lessen geo...

Kairos goes social along with $6M IPO to money tests of cancer medication

.With a trio of biotechs hitting the Nasdaq on Friday, it was quick and easy to skip a smaller-scale...